BC
TWST icon

Bridgefront Capital’s Twist Bioscience TWST Stock Holding History

Bridgefront Capital’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,482
Closed -$379K – 786
2025
Q3 		$379K Buy
+13,482
New +$408K 0.11% 325

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Bridgefront Capital's TWST Position: Q4 2025 in Review

Bridgefront Capital sold out of Twist Bioscience (TWST) in Q4 2025, closing a stake of 13,482 shares — an estimated $379K sold.

Bridgefront Capital first reported a position in TWST in Q3 2025 and held it in 1 quarter. The position peaked at $379K in Q3 2025. 243 funds tracked by Wall St. Rank hold TWST as of Q4 2025.

  • Bridgefront Capital reported no remaining Twist Bioscience position as of Q4 2025 after selling out during the quarter.
  • Bridgefront Capital sold 13,482 Twist Bioscience shares in Q4 2025, an estimated $379K.
  • Bridgefront Capital first reported a position in Twist Bioscience in Q3 2025 and held it in 1 quarter.
  • Bridgefront Capital's Twist Bioscience position peaked at $379K in Q3 2025.
  • 243 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2025.

Based on Bridgefront Capital's 13F filing for Q4 2025, filed 13 Feb 2026.